ID   ANPRA_RAT               Reviewed;        1057 AA.
AC   P18910; A1A5N8;
DT   01-NOV-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1990, sequence version 1.
DT   02-OCT-2024, entry version 201.
DE   RecName: Full=Atrial natriuretic peptide receptor 1;
DE            EC=4.6.1.2 {ECO:0000269|PubMed:2563900};
DE   AltName: Full=Atrial natriuretic peptide receptor type A;
DE            Short=ANP-A;
DE            Short=ANPR-A;
DE            Short=NPR-A;
DE   AltName: Full=Guanylate cyclase A;
DE            Short=GC-A {ECO:0000303|PubMed:2563900};
DE   Flags: Precursor;
GN   Name=Npr1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=2563900; DOI=10.1038/338078a0;
RA   Chinkers M., Garbers D.L., Chang M.S., Lowe D.G., Chin H., Goeddel D.V.,
RA   Schulz S.;
RT   "A membrane form of guanylate cyclase is an atrial natriuretic peptide
RT   receptor.";
RL   Nature 338:78-83(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=1978722; DOI=10.1016/s0021-9258(17)30520-3;
RA   Yamaguchi M., Rutledge L.J., Garbers D.L.;
RT   "The primary structure of the rat guanylyl cyclase A/atrial natriuretic
RT   peptide receptor gene.";
RL   J. Biol. Chem. 265:20414-20420(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF GLU-338 AND LEU-364.
RX   PubMed=1679239; DOI=10.1073/pnas.88.17.7882;
RA   Duda T., Goraczniak R.M., Sharma R.K.;
RT   "Site-directed mutational analysis of a membrane guanylate cyclase cDNA
RT   reveals the atrial natriuretic factor signaling site.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:7882-7886(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION AT SER-525; THR-528; SER-530; SER-534; SER-538 AND THR-541,
RP   AND MUTAGENESIS OF SER-522; SER-525; THR-528; SER-530; SER-534; SER-538;
RP   THR-541 AND THR-542.
RX   PubMed=9528788; DOI=10.1128/mcb.18.4.2164;
RA   Potter L.R., Hunter T.;
RT   "Phosphorylation of the kinase homology domain is essential for activation
RT   of the A-type natriuretic peptide receptor.";
RL   Mol. Cell. Biol. 18:2164-2172(1998).
RN   [6]
RP   PHOSPHORYLATION AT SER-515; SER-525; THR-528; SER-530; SER-534; SER-538 AND
RP   THR-541.
RX   PubMed=20977274; DOI=10.1021/bi101700e;
RA   Yoder A.R., Stone M.D., Griffin T.J., Potter L.R.;
RT   "Mass spectrometric identification of phosphorylation sites in guanylyl
RT   cyclase A and B.";
RL   Biochemistry 49:10137-10145(2010).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 29-463 IN COMPLEX WITH CHLORIDE,
RP   MUTAGENESIS OF GLU-197 AND HIS-213, SUBUNIT, AND GLYCOSYLATION AT ASN-208.
RX   PubMed=10894551; DOI=10.1038/35017602;
RA   van den Akker F., Zhang X., Miyagi M., Huo X., Misono K.S., Yee V.C.;
RT   "Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-
RT   coupled receptor.";
RL   Nature 406:101-104(2000).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (2.95 ANGSTROMS) OF 29-463 IN COMPLEX WITH NPPA AND
RP   CHLORIDE, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-208.
RX   PubMed=15117952; DOI=10.1074/jbc.m313222200;
RA   Ogawa H., Qiu Y., Ogata C.M., Misono K.S.;
RT   "Crystal structure of hormone-bound atrial natriuretic peptide receptor
RT   extracellular domain: rotation mechanism for transmembrane signal
RT   transduction.";
RL   J. Biol. Chem. 279:28625-28631(2004).
CC   -!- FUNCTION: Receptor for the atrial natriuretic peptide NPPA/ANP and the
CC       brain natriuretic peptide NPPB/BNP which are potent vasoactive hormones
CC       playing a key role in cardiovascular homeostasis. Has guanylate cyclase
CC       activity upon binding of the ligand. {ECO:0000269|PubMed:2563900}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=GTP = 3',5'-cyclic GMP + diphosphate; Xref=Rhea:RHEA:13665,
CC         ChEBI:CHEBI:33019, ChEBI:CHEBI:37565, ChEBI:CHEBI:57746; EC=4.6.1.2;
CC         Evidence={ECO:0000269|PubMed:2563900};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13666;
CC         Evidence={ECO:0000269|PubMed:2563900};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10894551,
CC       ECO:0000269|PubMed:15117952}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:2563900}; Single-
CC       pass type I membrane protein {ECO:0000255}.
CC   -!- PTM: Phosphorylation of the protein kinase-like domain is required for
CC       full activation by ANP. {ECO:0000269|PubMed:20977274,
CC       ECO:0000269|PubMed:9528788}.
CC   -!- SIMILARITY: Belongs to the adenylyl cyclase class-4/guanylyl cyclase
CC       family. {ECO:0000255|PROSITE-ProRule:PRU00099}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X14773; CAA32881.1; -; mRNA.
DR   EMBL; J05677; AAA41200.1; -; Genomic_DNA.
DR   EMBL; M74535; AAA41202.1; -; mRNA.
DR   EMBL; BC128742; AAI28743.1; -; mRNA.
DR   PIR; S03348; OYRTR.
DR   RefSeq; NP_036745.1; NM_012613.1.
DR   RefSeq; XP_006232653.1; XM_006232591.3.
DR   PDB; 1DP4; X-ray; 2.00 A; A/C=29-463.
DR   PDB; 1T34; X-ray; 2.95 A; A/B=29-463.
DR   PDB; 3A3K; X-ray; 2.50 A; A/B=29-463.
DR   PDB; 7BRG; X-ray; 2.45 A; A/B=29-463.
DR   PDB; 7BRH; X-ray; 2.45 A; A/B=29-463.
DR   PDB; 7BRI; X-ray; 2.45 A; A/B=29-463.
DR   PDB; 7BRJ; X-ray; 2.70 A; A/B=29-463.
DR   PDB; 7BRK; X-ray; 2.85 A; A/B=29-463.
DR   PDB; 7BRL; X-ray; 3.20 A; A/B=29-463.
DR   PDBsum; 1DP4; -.
DR   PDBsum; 1T34; -.
DR   PDBsum; 3A3K; -.
DR   PDBsum; 7BRG; -.
DR   PDBsum; 7BRH; -.
DR   PDBsum; 7BRI; -.
DR   PDBsum; 7BRJ; -.
DR   PDBsum; 7BRK; -.
DR   PDBsum; 7BRL; -.
DR   AlphaFoldDB; P18910; -.
DR   SMR; P18910; -.
DR   ComplexPortal; CPX-33; ANPR-A receptor complex.
DR   IntAct; P18910; 2.
DR   MINT; P18910; -.
DR   STRING; 10116.ENSRNOP00000020307; -.
DR   BindingDB; P18910; -.
DR   ChEMBL; CHEMBL5277; -.
DR   DrugCentral; P18910; -.
DR   GuidetoPHARMACOLOGY; 1747; -.
DR   GlyCosmos; P18910; 6 sites, No reported glycans.
DR   GlyGen; P18910; 6 sites.
DR   iPTMnet; P18910; -.
DR   PhosphoSitePlus; P18910; -.
DR   jPOST; P18910; -.
DR   PaxDb; 10116-ENSRNOP00000020307; -.
DR   Ensembl; ENSRNOT00000020307.4; ENSRNOP00000020307.2; ENSRNOG00000014684.4.
DR   Ensembl; ENSRNOT00055038069; ENSRNOP00055031060; ENSRNOG00055022138.
DR   Ensembl; ENSRNOT00060055935; ENSRNOP00060046263; ENSRNOG00060032283.
DR   Ensembl; ENSRNOT00065046512; ENSRNOP00065038139; ENSRNOG00065026951.
DR   GeneID; 24603; -.
DR   KEGG; rno:24603; -.
DR   UCSC; RGD:3195; rat.
DR   AGR; RGD:3195; -.
DR   CTD; 4881; -.
DR   RGD; 3195; Npr1.
DR   eggNOG; KOG1023; Eukaryota.
DR   GeneTree; ENSGT00940000156223; -.
DR   HOGENOM; CLU_001072_1_3_1; -.
DR   InParanoid; P18910; -.
DR   OMA; KCAYEKS; -.
DR   OrthoDB; 3683909at2759; -.
DR   PhylomeDB; P18910; -.
DR   TreeFam; TF106338; -.
DR   BRENDA; 4.6.1.2; 5301.
DR   Reactome; R-RNO-5578768; Physiological factors.
DR   EvolutionaryTrace; P18910; -.
DR   PRO; PR:P18910; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000014684; Expressed in lung and 19 other cell types or tissues.
DR   GO; GO:1990620; C:ANPR-A receptor complex; IPI:ComplexPortal.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0004016; F:adenylate cyclase activity; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004383; F:guanylate cyclase activity; IDA:RGD.
DR   GO; GO:0042562; F:hormone binding; ISO:RGD.
DR   GO; GO:0016941; F:natriuretic peptide receptor activity; ISO:RGD.
DR   GO; GO:0017046; F:peptide hormone binding; ISO:RGD.
DR   GO; GO:0001653; F:peptide receptor activity; IBA:GO_Central.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0097746; P:blood vessel diameter maintenance; IEA:UniProtKB-KW.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IMP:RGD.
DR   GO; GO:0006182; P:cGMP biosynthetic process; ISO:RGD.
DR   GO; GO:0019934; P:cGMP-mediated signaling; IMP:RGD.
DR   GO; GO:0042417; P:dopamine metabolic process; IMP:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:RGD.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0010753; P:positive regulation of cGMP-mediated signaling; IDA:RGD.
DR   GO; GO:0007168; P:receptor guanylyl cyclase signaling pathway; IDA:ComplexPortal.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   CDD; cd07302; CHD; 1.
DR   CDD; cd06385; PBP1_NPR_A; 1.
DR   CDD; cd14042; PK_GC-A_B; 1.
DR   Gene3D; 3.40.50.2300; -; 2.
DR   Gene3D; 3.30.70.1230; Nucleotide cyclase; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR001054; A/G_cyclase.
DR   InterPro; IPR018297; A/G_cyclase_CS.
DR   InterPro; IPR001828; ANF_lig-bd_rcpt.
DR   InterPro; IPR001170; ANPR/GUC.
DR   InterPro; IPR050401; Cyclic_nucleotide_synthase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR029787; Nucleotide_cyclase.
DR   InterPro; IPR028082; Peripla_BP_I.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   PANTHER; PTHR11920:SF300; ATRIAL NATRIURETIC PEPTIDE RECEPTOR 1; 1.
DR   PANTHER; PTHR11920; GUANYLYL CYCLASE; 1.
DR   Pfam; PF01094; ANF_receptor; 1.
DR   Pfam; PF00211; Guanylate_cyc; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR00255; NATPEPTIDER.
DR   SMART; SM00044; CYCc; 1.
DR   SUPFAM; SSF55073; Nucleotide cyclase; 1.
DR   SUPFAM; SSF53822; Periplasmic binding protein-like I; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00458; ANF_RECEPTORS; 1.
DR   PROSITE; PS00452; GUANYLATE_CYCLASE_1; 1.
DR   PROSITE; PS50125; GUANYLATE_CYCLASE_2; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; cGMP biosynthesis; Chloride; Disulfide bond; Glycoprotein;
KW   GTP-binding; Lyase; Membrane; Nucleotide-binding; Phosphoprotein; Receptor;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix; Vasoactive.
FT   SIGNAL          1..28
FT   CHAIN           29..1057
FT                   /note="Atrial natriuretic peptide receptor 1"
FT                   /id="PRO_0000012362"
FT   TOPO_DOM        29..469
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        470..490
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        491..1057
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          524..801
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          872..1002
FT                   /note="Guanylate cyclase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00099"
FT   BINDING         81
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000269|PubMed:10894551,
FT                   ECO:0000269|PubMed:15117952"
FT   BINDING         113
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000269|PubMed:10894551,
FT                   ECO:0000269|PubMed:15117952"
FT   BINDING         114
FT                   /ligand="chloride"
FT                   /ligand_id="ChEBI:CHEBI:17996"
FT                   /evidence="ECO:0000269|PubMed:10894551,
FT                   ECO:0000269|PubMed:15117952"
FT   MOD_RES         515
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20977274"
FT   MOD_RES         525
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20977274,
FT                   ECO:0000269|PubMed:9528788"
FT   MOD_RES         528
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:20977274,
FT                   ECO:0000269|PubMed:9528788"
FT   MOD_RES         530
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20977274,
FT                   ECO:0000269|PubMed:9528788"
FT   MOD_RES         534
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20977274,
FT                   ECO:0000269|PubMed:9528788"
FT   MOD_RES         538
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:20977274,
FT                   ECO:0000269|PubMed:9528788"
FT   MOD_RES         541
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:20977274,
FT                   ECO:0000269|PubMed:9528788"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT   CARBOHYD        208
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:10894551,
FT                   ECO:0000269|PubMed:15117952"
FT   CARBOHYD        334
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        375
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        382
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        423
FT                   /note="N-linked (GlcNAc...) asparagine"
FT   DISULFID        88..114
FT                   /evidence="ECO:0000269|PubMed:15117952"
FT   DISULFID        192..241
FT                   /evidence="ECO:0000269|PubMed:15117952"
FT   DISULFID        451..460
FT                   /evidence="ECO:0000269|PubMed:15117952"
FT   MUTAGEN         197
FT                   /note="E->K: Abolishes hormone binding."
FT                   /evidence="ECO:0000269|PubMed:10894551"
FT   MUTAGEN         213
FT                   /note="H->D: Abolishes hormone binding."
FT                   /evidence="ECO:0000269|PubMed:10894551"
FT   MUTAGEN         338
FT                   /note="E->H: Decreased ANP-dependent guanylate cyclase
FT                   activity; when associated with P-364."
FT                   /evidence="ECO:0000269|PubMed:1679239"
FT   MUTAGEN         364
FT                   /note="L->P: Decreased ANP-dependent guanylate cyclase
FT                   activity; when associated with H-338."
FT                   /evidence="ECO:0000269|PubMed:1679239"
FT   MUTAGEN         364
FT                   /note="Missing: Loss of ANP binding and ANP-dependent
FT                   guanylate cyclase activities."
FT                   /evidence="ECO:0000269|PubMed:1679239"
FT   MUTAGEN         522
FT                   /note="S->A: No effect on phosphorylation, 15% loss of ANP-
FT                   dependent activity."
FT                   /evidence="ECO:0000269|PubMed:9528788"
FT   MUTAGEN         525
FT                   /note="S->A: Reduced phosphorylation, 80% loss of ANP-
FT                   dependent activity."
FT                   /evidence="ECO:0000269|PubMed:9528788"
FT   MUTAGEN         525
FT                   /note="S->E: No effect on ANP-dependent activity."
FT                   /evidence="ECO:0000269|PubMed:9528788"
FT   MUTAGEN         528
FT                   /note="T->A: Reduced phosphorylation, 50% loss of ANP-
FT                   dependent activity."
FT                   /evidence="ECO:0000269|PubMed:9528788"
FT   MUTAGEN         530
FT                   /note="S->A: Reduced phosphorylation, 50% loss of ANP-
FT                   dependent activity."
FT                   /evidence="ECO:0000269|PubMed:9528788"
FT   MUTAGEN         534
FT                   /note="S->A: Reduced phosphorylation, 50% loss of ANP-
FT                   dependent activity."
FT                   /evidence="ECO:0000269|PubMed:9528788"
FT   MUTAGEN         538
FT                   /note="S->A: Reduced phosphorylation, 60% loss of CNP-
FT                   dependent activity."
FT                   /evidence="ECO:0000269|PubMed:9528788"
FT   MUTAGEN         541
FT                   /note="T->A: Markedly reduced phosphorylation, 50% loss of
FT                   CNP-dependent activity."
FT                   /evidence="ECO:0000269|PubMed:9528788"
FT   MUTAGEN         542
FT                   /note="T->A: No effect on phosphorylation, 30% loss of ANP-
FT                   dependent activity."
FT                   /evidence="ECO:0000269|PubMed:9528788"
FT   CONFLICT        366
FT                   /note="Q -> H (in Ref. 3; AAA41202)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        392
FT                   /note="L -> P (in Ref. 3; AAA41202)"
FT                   /evidence="ECO:0000305"
FT   STRAND          30..37
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           48..63
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          68..71
FT                   /evidence="ECO:0007829|PDB:7BRH"
FT   STRAND          73..80
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          86..88
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           92..104
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          107..110
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           115..128
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          132..135
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           140..143
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   TURN            145..147
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          151..153
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           158..172
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          176..183
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          186..188
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           191..207
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          210..216
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           221..223
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           224..234
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          236..242
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           244..256
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   TURN            261..263
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          265..269
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          279..282
FT                   /evidence="ECO:0007829|PDB:7BRG"
FT   STRAND          291..293
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           295..301
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           302..304
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          305..310
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           316..333
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           341..343
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           344..365
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   HELIX           373..378
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   TURN            379..382
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          383..387
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          390..394
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          398..400
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          404..409
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   TURN            411..413
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          416..422
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   TURN            424..426
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          429..432
FT                   /evidence="ECO:0007829|PDB:1DP4"
FT   STRAND          440..443
FT                   /evidence="ECO:0007829|PDB:7BRI"
SQ   SEQUENCE   1057 AA;  118951 MW;  9EA9AE685AC05816 CRC64;
     MPGSRRVRPR LRALLLLPPL LLLRGGHASD LTVAVVLPLT NTSYPWSWAR VGPAVELALA
     RVKARPDLLP GWTVRMVLGS SENAAGVCSD TAAPLAAVDL KWEHSPAVFL GPGCVYSAAP
     VGRFTAHWRV PLLTAGAPAL GIGVKDEYAL TTRTGPSHVK LGDFVTALHR RLGWEHQALV
     LYADRLGDDR PCFFIVEGLY MRVRERLNIT VNHQEFVEGD PDHYPKLLRA VRRKGRVIYI
     CSSPDAFRNL MLLALNAGLT GEDYVFFHLD VFGQSLKSAQ GLVPQKPWER GDGQDRSARQ
     AFQAAKIITY KEPDNPEYLE FLKQLKLLAD KKFNFTVEDG LKNIIPASFH DGLLLYVQAV
     TETLAQGGTV TDGENITQRM WNRSFQGVTG YLKIDRNGDR DTDFSLWDMD PETGAFRVVL
     NYNGTSQELM AVSEHKLYWP LGYPPPDVPK CGFDNEDPAC NQDHFSTLEV LALVGSLSLI
     SFLIVSFFIY RKMQLEKELV SELWRVRWED LQPSSLERHL RSAGSRLTLS GRGSNYGSLL
     TTEGQFQVFA KTAYYKGNLV AVKRVNRKRI ELTRKVLFEL KHMRDVQNEH LTRFVGACTD
     PPNICILTEY CPRGSLQDIL ENESITLDWM FRYSLTNDIV KGMLFLHNGA ICSHGNLKSS
     NCVVDGRFVL KITDYGLESF RDPEPEQGHT LFAKKLWTAP ELLRMASPPA RGSQAGDVYS
     FGIILQEIAL RSGVFYVEGL DLSPKEIIER VTRGEQPPFR PSMDLQSHLE ELGQLMQRCW
     AEDPQERPPF QQIRLALRKF NKENSSNILD NLLSRMEQYA NNLEELVEER TQAYLEEKRK
     AEALLYQILP HSVAEQLKRG ETVQAEAFDS VTIYFSDIVG FTALSAESTP MQVVTLLNDL
     YTCFDAVIDN FDVYKVETIG DAYMVVSGLP VRNGQLHARE VARMALALLD AVRSFRIRHR
     PQEQLRLRIG IHTGPVCAGV VGLKMPRYCL FGDTVNTASR MESNGEALKI HLSSETKAVL
     EEFDGFELEL RGDVEMKGKG KVRTYWLLGE RGCSTRG
//
